Oxxon Pharmaccines, a biotechnology company based in Oxford, England, was about to open a US Office in Boston, MA, and to change its name to Oxxon Therapeutics. Oxxon wished to make its presence known in Boston—an area commonly flooded with daily biotechnology news-- in order to facilitate the development and commercialization of its products in the US.

Anita Harris Communications  joined The Communications Strategy Group Inc. of Marblehead, MA and DeFacto Communications, of London, to develop and execute a highly coordinated rollout plan to announce the Oxxon news. The effort included personal introductions to highly placed biotechnology, government and industry leaders and a cocktail reception at the British consulate. CSGI handled the introductions and reception, DeFacto wrote a press release, and Anita Harris orchestrated outreach to the press,  suggesting to  business and biotechnology reporters that they use Oxxon's move as an example of "insourcing," in which international companies hire US workers to work on US soil.

As a result of the team's personal outreach and cocktail reception, Oxxon is now well-positioned to conduct business in the United States. The company is currently recruiting staff and developing relationships with potential partners; it plans to begin reaching out to US-based investment bankers and venture capitalists in the near future.